Aeon, a Zurich, Switzerland-based AI preventive well being platform, raised €8.2m in seed funding.
The spherical was led by Concentric, with participation from Calm/Storm Ventures, GoHub, Kadmos, EWOR and angel Daniel Gutenberg.
The corporate intends to make use of the funds to broaden operations and its enterprise attain. The brand new capital will help Aeon’s growth throughout Switzerland, Germany, and the UK, with additional worldwide markets deliberate. It is going to even be used to speed up partnerships with insurers and employers to enhance entry and affordability, and to boost its multi-modal AI platform for earlier and extra exact diagnostics. Aeon plans to open greater than 10 new places within the coming months because it scales its scientific community.
Led by CEO Tim Seithe, and CPO Samuel Frey, Aeon is constructing a brand new class of preventive well being – combining AI, MRI scans, genetic and blood testing right into a single platform for early detection and personalised danger prediction. It provides a full-body test up well being scan eligible for insurance coverage protection.
Aeon makes use of AI in 3 ways:
- Automated imaging evaluation: Detecting and quantifying anomalies on MRI scans, enhancing the velocity and consistency of scientific evaluations
- Cross-validation: Correlating MRI, blood, and genetic information to scale back false positives and enhance scientific relevance
- Predictive modeling: Producing a personalised danger profile for every consumer, forecasting the chance of over 500 circumstances and enabling focused prevention
Since launching in 2024, the system has already helped detect early-stage cancers, aneurysms, Alzheimer’s, and different essential circumstances, typically in individuals who felt completely wholesome.
The platform additionally provides full-body test ups eligible for reimbursement by well being insurers, and has already signed offers with Switzerland’s largest insurance coverage suppliers, together with KPT.
FinSMEs
05/06/2025
